EP1474196A1 — Methods and systems for operating an aerosol generator
Assigned to Novartis AG · Expires 2004-11-10 · 22y expired
What this patent protects
A nebule (28) having an identification marker/label (35) which is adapted to engage an aerosol generator (22). The marker/label (35) can be sensed by a sensing device (34) on the aerosol generator (22) so as to identify the contents of the nebule (28) for use by the aerosol contr…
USPTO Abstract
A nebule (28) having an identification marker/label (35) which is adapted to engage an aerosol generator (22). The marker/label (35) can be sensed by a sensing device (34) on the aerosol generator (22) so as to identify the contents of the nebule (28) for use by the aerosol controller (30). The controller (30) can then control the aerosol generator (22) based upon the identity of the contents of the nebule.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.